Bromide

Bromide

SCHEMBL6993690

Br.Cc1ccc(OCC(=O)O)cn1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
NR4A1 P22736 1/20 0.50
APEX1 P27695 1/20 0.50
ALOX15 P16050 1/20 0.50
MCL1 Q07820 1/20 0.50
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
TSHR P16473 1/20 0.46
PTPN7 P35236 2/20 0.46
FFAR1 O14842 2/20 0.46
MEN1 O00255 1/20 0.45
PTPN12 Q05209 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2435587 0.98 ALOX15 (0.52) SMN1; SMN2NR4A1APEX1ALOX15MCL1
SCHEMBL29416383 0.98 ALOX15 (0.52) SMN1; SMN2NR4A1APEX1ALOX15MCL1
SCHEMBL13980911 0.83 MAPT (0.55) KMT2AMAPTTSHR
SCHEMBL6200661 0.80 NPC1 (0.57) SMN1; SMN2ALDH1A1KMT2AMAPTMEN1
SCHEMBL2438238 0.79 GAA (0.58) SMN1; SMN2ALDH1A1KMT2AMAPTTSHR
SCHEMBL16796518 0.77 LMNA (0.51) SMN1; SMN2ALOX15ALDH1A1KMT2AMAPT
SCHEMBL16421193 0.77 ALDH1A1 (0.49) SMN1; SMN2NR4A1APEX1ALOX15MCL1
SCHEMBL22711544 0.77 ALOX15 (0.52) SMN1; SMN2NR4A1APEX1ALOX15MCL1
SCHEMBL20331323 0.77 MAPT (0.57) SMN1; SMN2ALDH1A1KMT2AMAPT
SCHEMBL21211685 0.77 PTPN7 (0.61) SMN1; SMN2NR4A1APEX1ALOX15MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339692-A1 NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2003-09-03 EP disclosed
US-6472404-B1 HIV protease inhibitors HOFFMANN-LA ROCHE INC. 2002-10-29 US disclosed
WO-2002042277-A1 NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-05-30 WO disclosed